In a post hoc analysis of 1,121 SS patients in ALBIOS, there was a decreasing trend towards in 3-month mortality following albumin treatment (RR 0.87; 95% CI 0.77–0.99; p = 0.049) (Caironi et al., 2014), which is similar with our results. The gene discussed is ALB; the disease is synovial sarcoma.